ATE289813T1 - Typ v pde-hemmer zur behandlung von mukoviszidose - Google Patents

Typ v pde-hemmer zur behandlung von mukoviszidose

Info

Publication number
ATE289813T1
ATE289813T1 AT00920923T AT00920923T ATE289813T1 AT E289813 T1 ATE289813 T1 AT E289813T1 AT 00920923 T AT00920923 T AT 00920923T AT 00920923 T AT00920923 T AT 00920923T AT E289813 T1 ATE289813 T1 AT E289813T1
Authority
AT
Austria
Prior art keywords
treatment
type
cystic fibrosis
pde inhibitors
pde
Prior art date
Application number
AT00920923T
Other languages
English (en)
Inventor
Robert Leslie Dormer
Margaret Ann Mcpherson
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cardiff filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE289813T1 publication Critical patent/ATE289813T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00920923T 1999-04-22 2000-04-20 Typ v pde-hemmer zur behandlung von mukoviszidose ATE289813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909135.7A GB9909135D0 (en) 1999-04-22 1999-04-22 Cystic fibrosis medicaments
PCT/GB2000/001564 WO2000064424A2 (en) 1999-04-22 2000-04-20 Cystic fibrosis medicaments

Publications (1)

Publication Number Publication Date
ATE289813T1 true ATE289813T1 (de) 2005-03-15

Family

ID=10851966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00920923T ATE289813T1 (de) 1999-04-22 2000-04-20 Typ v pde-hemmer zur behandlung von mukoviszidose

Country Status (7)

Country Link
US (2) US6599907B1 (de)
EP (1) EP1194148B1 (de)
AT (1) ATE289813T1 (de)
AU (1) AU4133400A (de)
DE (1) DE60018422T2 (de)
GB (1) GB9909135D0 (de)
WO (1) WO2000064424A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202254D0 (en) * 2002-01-31 2002-03-20 Pfizer Ltd Prevention of scarring
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
CN100374441C (zh) * 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
DE602004022819D1 (de) * 2003-06-06 2009-10-08 Vertex Pharma Von atp-bindende kassette transportern
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US8012041B2 (en) * 2004-10-07 2011-09-06 Callaway Golf Company Golf club head with variable face thickness
US7101289B2 (en) * 2004-10-07 2006-09-05 Callaway Golf Company Golf club head with variable face thickness
JP5426878B2 (ja) * 2005-05-24 2014-02-26 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｐ−結合カセットトランスポーターのモジュレーター
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
US7753809B2 (en) * 2007-12-19 2010-07-13 Cackett Matthew T Driver with deep AFT cavity
MX2013002895A (es) * 2010-09-14 2013-06-05 Inst Biochemii I Biofizyki Pan Compuestos como moduladores de una proteina cftr mutante y su uso para tratar enfermedades asociadas con las deficiencias de la proteina cftr.
US9339515B2 (en) 2013-02-20 2016-05-17 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
NZ730475A (en) * 2014-10-29 2018-09-28 Dong A St Co Ltd Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728705A (en) * 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
US5602110A (en) * 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis

Also Published As

Publication number Publication date
WO2000064424A2 (en) 2000-11-02
US20030229117A1 (en) 2003-12-11
EP1194148A2 (de) 2002-04-10
US6936618B2 (en) 2005-08-30
US6599907B1 (en) 2003-07-29
DE60018422T2 (de) 2006-04-06
GB9909135D0 (en) 1999-06-16
EP1194148B1 (de) 2005-03-02
AU4133400A (en) 2000-11-10
WO2000064424A3 (en) 2001-06-07
WO2000064424A8 (en) 2001-10-18
DE60018422D1 (de) 2005-04-07

Similar Documents

Publication Publication Date Title
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
TW200510375A (en) New compounds
ATE556059T1 (de) Pyrazolderivate zur behandlung von hiv
DE60224189D1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
MY144659A (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
DE69811645D1 (de) Phtalazinonen
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
DE69911448D1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
MY134586A (en) Novel pyrroles derivatives as pharmaceutical agents
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
ATE289813T1 (de) Typ v pde-hemmer zur behandlung von mukoviszidose
DE60132600D1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
EA200000355A2 (ru) Промышленные изделия
HRP20090159T1 (en) Use of glucosidase inhibitors for therapy of mucovisidosis
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
ATE253359T1 (de) Antithrombotische mittel
MXPA03004023A (es) Compuestos quimicos.
DE60019946D1 (de) Antisense-modulation von x-verbundenen inhibitoren der apoptosis-expression
DE60213798D1 (de) Carbolinderivate als pdev inhibitoren
ATE286395T1 (de) Antithrombotische mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties